pancreatic cancer
Showing NaN - NaN of 102
Pancreatic Cancer, Advanced Cancer Trial in Boston, Chapel Hill (Hydroxychloroquine Sulfate, LY3214996)
Recruiting
- Pancreatic Cancer
- Advanced Cancer
- Hydroxychloroquine Sulfate
- LY3214996
-
Boston, Massachusetts
- +2 more
Apr 6, 2022
Colorectal Cancer (CRC), Endometrial Cancer, Melanoma Trial in United States (Pembrolizumab, itacitinib, INCB050465)
Completed
- Colorectal Cancer (CRC)
- +10 more
- Pembrolizumab
- +2 more
-
San Francisco, California
- +16 more
Mar 30, 2022
Assessment and Implications for Personalized Therapy
Active, not recruiting
- Pancreatic Cancer
-
Boston, MassachusettsDana Farber Cancer Institute
Mar 28, 2022
Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)
Completed
- Advanced Solid Tumors
- +6 more
- Cabiralizumab
- Nivolumab
-
Scottsdale, Arizona
- +38 more
Jan 5, 2022
Cancer of Pancreas, Cancer of the Pancreas, Tumors, Pancreatic Trial in Boston, New York (Talabostat Mesylate)
Withdrawn
- Cancer of Pancreas
- +4 more
- Talabostat Mesylate
-
Boston, Massachusetts
- +1 more
Feb 8, 2022
Pancreatic Cancer Trial in Boston (LUM Imaging System)
Not yet recruiting
- Pancreatic Cancer
- LUM Imaging System
-
Boston, MassachusettsMassachusetts General Hospital
Feb 7, 2022
Mesothelioma, Bladder Cancer, Melanoma Trial in Australia, Canada, United States (MGD009)
Terminated
- Mesothelioma
- +12 more
- MGD009
-
Los Angeles, California
- +19 more
Feb 4, 2022
Pancreatic Cancer, Stereotactic Body Radiation Therapy Trial in United States (Avasopasem (GC4419), Placebo, Stereotactic
Completed
- Pancreatic Cancer
- Stereotactic Body Radiation Therapy
- Avasopasem (GC4419)
- +2 more
-
Tampa, Florida
- +5 more
Jan 6, 2022
Pancreatic Cancer Trial in Israel, United States (Stereotactic MRI-guided On-table Adaptive Radiation Therapy)
Active, not recruiting
- Pancreatic Cancer
- Stereotactic MRI-guided On-table Adaptive Radiation Therapy
-
Los Angeles, California
- +12 more
Nov 18, 2021
Pancreatic Cancer, Metastatic Pancreatic Cancer Trial in Boston (Niraparib, Dostarlimab, Radiation)
Active, not recruiting
- Pancreatic Cancer
- Metastatic Pancreatic Cancer
- Niraparib
- +2 more
-
Boston, Massachusetts
- +2 more
Oct 18, 2021
Pancreatic Cancer Trial in United States (Pembrolizumab, Neoadjuvant Chemoradiation)
Recruiting
- Pancreatic Cancer
- Pembrolizumab
- Neoadjuvant Chemoradiation
-
Phoenix, Arizona
- +5 more
Aug 11, 2021
Gastric Adenocarcinoma, Esophageal Cancer, Hepatocellular Carcinoma Trial in United States (Sacituzumab Govitecan-hziy (SG))
Completed
- Gastric Adenocarcinoma
- +15 more
- Sacituzumab Govitecan-hziy (SG)
-
Aurora, Colorado
- +11 more
Aug 10, 2021
Liver Cancer, Anxiety Disorder, Depression Trial in United States (Early palliative care)
Completed
- Liver Cancer
- +9 more
- Early palliative care
-
La Jolla, California
- +22 more
Jul 22, 2021
Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Taiwan, United States (AbGn-107)
Terminated
- Gastric Cancer
- +3 more
- AbGn-107
-
Phoenix, Arizona
- +8 more
Jul 8, 2021
Pancreatic Cancer Trial in Boston (drug, radiation, procedure)
Active, not recruiting
- Pancreatic Cancer
- FOLFIRINOX
- +3 more
-
Boston, MassachusettsMassachusetts General Hospital
May 5, 2021
Microsatellite Stable Colorectal Cancer, Pancreatic Cancer, MSI High Colorectal Cancer Trial in Boston (Nivolumab, Ipilimumab,
Recruiting
- Microsatellite Stable Colorectal Cancer
- +2 more
- Nivolumab
- +2 more
-
Boston, MassachusettsMassachusetts general Hospital
Mar 24, 2021
Pancreatic Cancer Trial in Boston (Capecitabine, Hydroxychloroquine, Proton or Photon Radiation Therapy)
Unknown status
- Pancreatic Cancer
- Capecitabine
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Feb 1, 2021
Pancreatic Cancer Trial in Worldwide (Pegilodecakin, FOLFOX)
Pancreatic Cancer Trial in Boston (FOLFIRINOX, Losartan, Proton Beam Radiation)
Unknown status
- Pancreatic Cancer
- FOLFIRINOX
- +2 more
-
Boston, MassachusettsMassachusetts General Hospital
Sep 7, 2020
NSCLC, Small Cell Lung Cancer, Mesothelioma Trial in Boston (early palliative care)
Completed
- Non-small Cell Lung Cancer
- +6 more
- early palliative care
-
Boston, MassachusettsMassachusetts General Hospital
Sep 20, 2020